An increasing body of evidence has revealed that activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK)-activated protein kinase increases fatty acid oxidation by lowering the concentration of malonyl coenzyme A (CoA), an inhibitor of carnitine palmitoyl transferase 1. Studies carried out primarily in skeletal muscle suggest that AMPK modulates the concentration of malonyl CoA by concurrently phosphorylating and inhibiting acetyl CoA carboxylase (ACC), the rate limiting enzyme in malonyl CoA synthesis, and phosphorylating and activating malonyl CoA decarboxylase (MCD), an enzyme involved in its degradation. We have recently observed that AMPK and MCD activities are increased and ACC activity diminished in skeletal muscle, liver and, surprisingly, in adipose tissue 30 min following exercise (treadmill run) in normal rats. In liver and adipose tissue these changes were associated with a decrease in the activity of glycerol-3-phosphate acyltransferase (GPAT), which catalyses the first committed reaction in glycerolipid synthesis and, which like ACC, is phosphorylated and inhibited by AMPK. Similar changes in ACC, MCD and GPAT were observed following the administration of 5-aminoimidazole 4-carboxamide-riboside (AICAR), further indicating that the exerciseinduced alterations in these enzymes were AMPK-mediated. Conclusions: (1) AMPK plays a major role in regulating lipid metabolism in multiple tissues following exercise. (2) The net effect of its activation is to increase fatty acid oxidation and diminish glycerolipid synthesis. (3) The relevance of these findings to the regulation of muscle glycogen repletion in the post-exercise state and to the demonstrated ability of AMPK activation to decrease adiposity and increase insulin sensitivity in rodents remains to be determined.
A major factor regulating intracellular fatty acid oxidation is malonyl coenzyme A (CoA), an allosteric inhibitor of carnitine palmitoyltransferase (CPT1), the enzyme that controls the transfer of cytosolic long chain fatty acyl CoA (LCFA CoA) into mitochondria (McGarry & Brown 1997 , McGarry, 2002 . A large body of evidence has suggested that malonyl CoA levels diminish in exercising (contracting) rat and possibly human muscle as a result of the phosphorylation of acetyl CoA carboxylase (ACC), the rate limiting enzyme in its synthesis (Ruderman et al. 1999 , Winder & Hardie 1999 , Dean et al. 2000 , Winder & Hardie, 1996 . The evidence also suggests that this phosphorylation reaction is catalysed by adnosine monophosphate (AMP)-activated protein kinase (AMPK), an enzyme activated in many cells by a change in their energy state, as reflected by an increase in the AMP/ATP ratio (see Fig. 1 ). In this brief review, we will examine three lines of investigation from our laboratory that impact on this classic view of AMPK regulation and its effects on fatty acid metabolism during exercise:
(1) that AMPK also regulates malonyl CoA levels in muscle by activating malonyl CoA decarboxylase (MCD), (2) that AMPK activation is present well after the completion of exercise in muscle, and also in liver and adipose tissue, (3) these increases in AMPK post-exercise are associated with alterations in ACC and MCD activity in all three tissues and with a decrease in the activity of another AMPK-sensitive enzyme, glycerophosphate acyltransferase (GPAT), in liver and adipose tissue.
Malonyl CoA decarboxylase
Malonyl CoA decarboxylase catalyses the decarboxylation of malonyl CoA to form acetyl CoA. In liver, the enzyme is to a considerable extent localized to mitochondria and peroxisomes by specific targeting sequences (Voilley et al. 1999) ; however, a modest but significant percentage of enzyme protein appears to be cytosolic (M. Bendayan, M. Prentki, A.K. Saha, N. Ruderman, unpublished data) . Its distribution in skeletal muscle is not known. Presumably the role of this cytosolic MCD is to jointly regulate malonyl CoA levels with ACC, at least in selected situations. This notion had not been directly tested in skeletal muscle, however. For this reason, we assayed MCD activity in 500 g supernatant fractions of control and contracting rat muscle using both (NH 4 ) 2 SO 4 precipitation and immunoprecipitation with an antibody specific for the N-terminus of MCD to obtain purified enzyme (Saha et al. 2000) . We found that contractions induced by electrical stimulation of the sciatic nerve caused a 2-fold increase in MCD activity within 2 min and that this was paralleled temporally by increases and decreases in the activity of AMPK and ACC, respectively (Fig. 2) . Similar changes were also observed in a rat extensor digitorum longus muscle preparation incubated in a medium containing the AMPK activator, AICAR. In both situations, the alterations in MCD and ACC activity were reversed by treatment with protein phosphatase 2A, suggesting they were because of phosphorylation (Fig. 3) . We concluded from these results that ACC and the cytosolic component of MCD are concurrently regulated by AMPK in contracting muscle and that observed changes in malonyl CoA are likely regulated by both enzymes.
The post-exercise state: skeletal muscle Following exercise, muscle oxidizes predominantly fatty acids to generate ATP, and glucose taken up by the muscle cell is used predominantly to replete glycogen stores (Ahlborg & Felig 1982, Bjorkman & Wahren Figure 2 Time course of changes in the activities of MCD, ACC and the a 2 isoform of AMPK during contractions. The sciatic nerve of one hindlimb was stimulated for periods ranging from 2 to 5 min and the other limb was used as the control. Immunoprecipitates were used to measure the activities of MCD, ACC and a 2 AMPK. Results are mean AE SE of four to five sets of muscles (from Saha et al. 2000) .
1988, Wolfe et al. 1990 , Wasserman et al. 2002 . Changes in ACC and AMPK in skeletal muscle have been shown to persist for 15-90 min post-exercise (Rasmussen et al. 1998) or electrically-induced contractions (Vavvas et al. 1997 , Hutber et al. 1997 , and could play a role in modulating these events. To examine this question, rats weighing 320-360 g were run for 30 min on a treadmill (21 m min )1 on a 12% grade), anesthetized with pentobarbital, and muscle and other tissues analysed for AMPK, ACC, MCD and GPAT. As shown in Figure 4 , 30 min after the cessation of the treadmill run, increases in a2-AMPK activity in muscle were present, and they were associated with significant increases in MCD activity and decreases in ACC activity and malonyl CoA concentration. No change was observed in the activity of the mitochondrial or microsomal form of GPAT (see below).
The post-exercise state: liver and adipose tissue
Increases in AMPK activity accompanied by decreases in malonyl CoA content and ACC activity have been noted in rat liver following exercise in some circumstances, but not others (Carlson & Winder 1999 ). In addition, MCD and GPAT were not determined in these studies, nor was the effect of the exercise on adipose tissue examined. As shown in Figure 5 , changes in AMPK, ACC, MCD and malonyl CoA very similar to those in muscle occurred in both liver and adipose tissue. In addition, the activity of mitochondrial GPAT, which was not altered in muscle, was diminished by approximately 50% in these tissues (Fig. 6) . No change in microsomal GPAT was observed. Also of note, the exercise caused proportionate increases in the activities of the a1-and a2-AMPK isoforms in liver, whereas in muscle predominantly a2-AMPK activity was increased (Figs 4 and 5). Overall, the net effect of these changes should 
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Figure 4 Effect of exercise on the concentration of malonyl CoA and the activities of AMPK (a 1 and a 2 isoforms), ACC and MCD in skeletal muscle. Rats were run on a treadmill for 30 min as described in the text. Values are mean AE SE; n ¼ 6 rats in each group. *Significantly different from resting control (adapted from Park et al. 2002) .
Ó 2003 Scandinavian Physiological Society be to increase fatty acid oxidation and decrease its esterification in liver and adipose tissue (Fig. 7) .
Effect of AICAR administration in vivo
That the observed enzymic changes were attributable to AMPK activation was further suggested by the observation that nearly identical changes in ACC, MCD and GPAT were observed in the three tissues 2 h following the subcutaneous administration of AICAR (250 mg kg )1 bw) (Park et al. 2002) .
Discussion
As a metabolic switch during exercise, AMPK has been viewed primarily in light of its ability to inhibit ACC and stimulate fatty-acid oxidation and insulin-independent glucose transport in skeletal muscle (Winder & Hardie 1999 , Musi et al. 2001 . The data reviewed here suggest that this perception of AMPK is incomplete. Thus, they indicate that (1) changes in AMPK as a result of exercise occur in tissues other than muscle, (2) the activities of ACC, MCD and GPAT are concurrently altered, and (3) alterations in these parameters persist or, to be more precise, are present well after the completion of exercise, when the energy state of the tissues should have long as returned to control values. The effect of prior exercise on AMPK activity in tissues other than skeletal muscle has received little attention. In the present study, rats were run at a rate of 21 m min )1 for 30 min on a 12% grade and were evaluated 30 min after the cessation of exercise. In rats run at a similar intensity, but for a longer time (16 m min )1 · 120 min on a 15% grade) Carlson & Winder (1999) failed to observe an increase in AMPK or a decrease in ACC activity in liver 0, 15 and 60 min post-exercise. On the other hand, they did find changes in these enzymes after brief, intense exercise (32 m min )1 · 10 min). The reason for these differing results remains to be determined. The coordinate changes of MCD and ACC in muscle, liver and adipose tissue after exercise underscores the apparent importance to these tissues of closely regulating the concentration of malonyl CoA. Such dual regulation of malonyl CoA synthesis and degradation by AMPK would presumably allow for more rapid and larger decreases in its concentration, and increases in fatty acid oxidation, during and after exercise. In light of this, it is surprising that the decrease in malonyl CoA concentration in these situations is generally at most 2-3-fold. As discussed elsewhere, this could be explained if malonyl CoA is compartmented, and its whole-cell concentration does not accurately reflect its concentration in the immediate vicinity of CPT1 (McGarry & Brown 1997 , Ruderman et al. 1999 .
A novel finding was that decreases in the activity of GPAT, the first committed enzyme in the synthesis of triglycerides and other glycerolipids, were present in liver and adipose tissue after exercise and they closely paralleled changes in AMPK, ACC and MCD. Early studies suggested that AMPK activation might diminish the synthesis of glycerolipids by decreasing the concentration of malonyl CoA, and secondarily increasing fatty acid oxidation and diminishing the cytosolic concentration of LCFA CoA (Ruderman et al. 1999) . Evidence that diminished glycerolipid synthesis could be related to AMPK-mediated inhibition of GPAT was first presented by Muoio et al. (1999) . In studies with cultured hepatocytes, they found that AICAR-induced increases in fatty acid oxidation (40-50%) were associated with inhibition of both triacylglycerol synthesis (30-40%) and mitochondrial GPAT activity (20-30%). They also found that incubation of hepatic mitochondria with recombinant AMPK produced a similar decrease in GPAT activity, suggesting that the effect of AICAR in the intact cell was AMPK-mediated (Muoio et al. 1999 ). Interestingly, AICAR had similar effects on fatty acid oxidation and esterification in an ? Figure 7 Coordinated changes in enzymes of lipid metabolism after exercise because of activation of AMPK: a proposed model. AMPK activation causes changes in ACC and MCD activity that lower the concentration of malonyl CoA in liver, muscle and adipose tissue. In addition, AMPK activation causes inhibition of GPAT in liver and adipose tissue. It has also been suggested that AMPK phosphorylates a cytosolic protein that activates CPT1 in liver, although this remains to be confirmed. The net effect of these changes is to increase fatty acid oxidation and decrease its esterification (from Park et al. 2002) . Ó 2003 Scandinavian Physiological Society incubated rat soleus muscle preparation and it also decreases malonyl CoA (Alam & Saggerson 1998) ; however, they were not associated with a decrease in mitochondrial GPAT (Muoio et al. 1999) . The investigators attributed this to the very low specific activity of GPAT in skeletal muscle. In keeping with the findings after exercise described here, they observed no change or a very delayed change in microsomal GPAT activity in hepatocytes incubated with AICAR. The data are consistent with the notion that AMPK modulates many of the metabolic events that take place in skeletal muscle following, as well as during exercise. We have addressed this question in a model similar to that of prior exercise, muscle post-hypoxia. Thus, in EDL pre-incubated in a medium gassed with 95% N/5% CO 2 for 60 min and then reoxygenated for 30 min, we found sustained increases in AMPK activity together with increases in insulin-independent glucose transport (not shown) and fatty acid oxidation and decreases in glucose incorporation into lipid and to a lesser extent its oxidation to CO 2 (Fig. 8) . Similar changes were observed after incubation with AICAR. These changes were associated with a greater than 8-fold increase in glycogen synthesis. AMPK activation probably contributes to glycogen repletion in muscle by increasing glucose transport and the concentration of glucose 6-phosphate, an activator of glycogen synthase. A direct effect of AMPK to activate glycogen synthase has been observed in some muscle fibre types by Goodyear and her co-workers (Aschenbach et al. 2002) ; however, others (Wojtaszewski et al. 2002) have shown that activation of AMPK by AICAR inhibits glycogen synthase in all three fibre types. Finally, two reports have suggested that activation of AMPK in muscle could be responsible for the enhanced sensitivity of the muscle cell to insulin that can persist for many hours following muscle contraction (Fisher et al. 2002 , Iglesias et al. 2002 . Earlier studies had suggested that this increase in insulin sensitivity is a major contributor to the rapid repletion of muscle glycogen stores in the post-exercise state (Richter et al. 1982 , Ruderman et al. 1986 .
The results also raise the possibility that AMPKmodulated changes in liver and adipose tissue contribute to the alterations in fuel homeostasis that characterize the post-exercise state. Thus, by increasing fatty acid oxidation in liver, AMPK activation could acutely stimulate hepatic glucose production (gluconeogenesis) (Rebrin et al. 1995) , thereby providing glucose for muscle to replete its glycogen stores. Likewise, AMPK activation in the adipocyte, by inhibiting GPAT would diminish fatty acid re-esterification, thereby enabling it to release more fatty acid into the circulation for the fuel needs of muscle and liver. It should be noted, however, that AMPK activation in liver both by AICAR treatment in vivo (Lochhead et al. 2000) and the expression of a constitutively active AMPK in cultured hepatocytes (Becard et al. 2001) has been shown to diminish the activity of some key gluconeogenic enzymes by effects on their transcription. If so, prolonged, unopposed effects of AMPK activation on liver would, if anything, impair hepatic glucose production and muscle glycogen repletion. Likewise, AMPK activation by AICAR has been reported to inhibit lipolysis in isolated adipocytes (Sullivan et al. 1994 , Winder & Hardie 1999 , an effect which theoretically would decrease the availability of FFA for liver and muscle. The physiological relevance of both of these findings is unclear, as the rate of gluconeogenesis by liver during and after exercise is, if anything, increased (Ahlborg & Felig 1982 , Bjorkman & Wahren 1988 , Wasserman et al. 2002 as are plasma FFA levels (Wolfe et al. 1990 , Wasserman et al. 2002 .
An intriguing question raised by these studies is why AMPK activity is increased in liver and adipose tissue 30 min post-exercise. AMP and ATP levels cannot be expected to be altered at this time or even during the exercise. This raises the possibility that the increase in AMPK in these tissues, and possibly in muscle, was mediated by a systemic factor (Fig. 9) . If so, one likely candidate would be catecholamines. It has long been known that plasma catecholamine levels increase during exercise (Christensen & Galbo 1983) , and recent studies by Minokoshi et al. (2002) have demonstrated that an increase in AMPK activity in muscle caused by infusing leptin is, at least in part, a-adrenergically mediated. In addition, Moule & Denton (1998) have shown that the b-adrenergic agonist isoproterenol increases AMPK activity in isolated adipocytes, and we have made a similar observation in incubated rat muscle (Fig. 10) . Finally, the data suggest AMPK concurrently increases fatty acid oxidation and diminishes its esterification in multiple tissues in the post-exercise state. The immediate implications of this dual effect on fuel homeostasis have already been discussed. Whether it has longer-term implications for gene expression in these tissues (Park et al. 2002) or for such problems as insulin resistance, obesity and lipotoxicity, all of which are associated with increases in tissue triglyceride deposition, remains to be determined (Ruderman et al. 1999 , Unger & Orci 2001 , Unger 2002 . Figure 10 Activation of AMPK in rat soleus muscle incubated with isoproterenol for 60 min. Solei were incubated with 1 or 10 lm isoproterenol with the muscle from the contralateral limb serving as control. Since the effect of isoproterenol at the two concentrations was the same, the data were pooled. Statistical analysis is based on a paired companion of the control and treated muscles. Activity is expressed as pmol min )1 mg )1 supernatent protein (V. Kaushik et al., unpublished data). *P < 0.004.
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